These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Dendritic cells support homeostatic expansion of Foxp3+ regulatory T cells in Foxp3.LuciDTR mice. Suffner J; Hochweller K; Kühnle MC; Li X; Kroczek RA; Garbi N; Hämmerling GJ J Immunol; 2010 Feb; 184(4):1810-20. PubMed ID: 20083650 [TBL] [Abstract][Full Text] [Related]
9. Dynamics of peripheral tolerance and immune regulation mediated by Treg. Sakaguchi S; Wing K; Yamaguchi T Eur J Immunol; 2009 Sep; 39(9):2331-6. PubMed ID: 19662638 [TBL] [Abstract][Full Text] [Related]
10. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection. Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253 [TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms of regulatory T cell development and suppressive function. Kim JM Prog Mol Biol Transl Sci; 2010; 92():279-314. PubMed ID: 20800825 [TBL] [Abstract][Full Text] [Related]
12. Changes of regulatory T cells and FoxP3 gene expression in the aging process and its relationship with lung tumors in humans and mice. Pan XD; Mao YQ; Zhu LJ; Li J; Xie Y; Wang L; Zhang GB Chin Med J (Engl); 2012 Jun; 125(11):2004-11. PubMed ID: 22884069 [TBL] [Abstract][Full Text] [Related]
13. CD4+CD25+Foxp3+ regulatory T cells are dispensable for controlling CD8+ T cell-mediated lung inflammation. Tosiek MJ; Gruber AD; Bader SR; Mauel S; Hoymann HG; Prettin S; Tschernig T; Buer J; Gereke M; Bruder D J Immunol; 2011 Jun; 186(11):6106-18. PubMed ID: 21518973 [TBL] [Abstract][Full Text] [Related]
14. The significantly enhanced frequency of functional CD4+CD25+Foxp3+ T regulatory cells in therapeutic dose aspirin-treated mice. Javeed A; Zhang B; Qu Y; Zhang A; Sun C; Zhang L; Liu J; Zeng C; Zhao Y Transpl Immunol; 2009 Mar; 20(4):253-60. PubMed ID: 19146957 [TBL] [Abstract][Full Text] [Related]
15. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro. Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692 [TBL] [Abstract][Full Text] [Related]
16. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts. Giorgini A; Noble A J Leukoc Biol; 2007 Nov; 82(5):1053-61. PubMed ID: 17684039 [TBL] [Abstract][Full Text] [Related]
17. Isolation strategies of regulatory T cells for clinical trials: phenotype, function, stability, and expansion capacity. Ukena SN; Höpting M; Velaga S; Ivanyi P; Grosse J; Baron U; Ganser A; Franzke A Exp Hematol; 2011 Dec; 39(12):1152-60. PubMed ID: 21864487 [TBL] [Abstract][Full Text] [Related]
18. Genome-wide identification of human FOXP3 target genes in natural regulatory T cells. Sadlon TJ; Wilkinson BG; Pederson S; Brown CY; Bresatz S; Gargett T; Melville EL; Peng K; D'Andrea RJ; Glonek GG; Goodall GJ; Zola H; Shannon MF; Barry SC J Immunol; 2010 Jul; 185(2):1071-81. PubMed ID: 20554955 [TBL] [Abstract][Full Text] [Related]
19. Suppression of alloimmunity in mice by regulatory T cells converted with conditioned media. Teng L; Liu L; Su Y; Yuan X; Li J; Fu Q; Chen S; Wang C J Surg Res; 2011 Dec; 171(2):797-806. PubMed ID: 20538297 [TBL] [Abstract][Full Text] [Related]
20. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets. Pyzik M; Piccirillo CA J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]